Cited by 58Liver Diseases and ImmunityClinical practice guidelines implementationPediatric Hepatobiliary Diseases and Treatments

An integrated care pathway improves quality of life in Primary Biliary Cirrhosis

Open access
Jones, D. E.J., Sutcliffe, K., Pairman, J., Wilton, K., Newton, J. L.·2008·QJM

Abstract

BACKGROUND: Clinical management of the chronic autoimmune liver disease, Primary Biliary Cirrhosis (PBC) involves addressing the underlying liver disease and a range of symptoms independent of liver disease severity. We have formally explored how these two perspectives of chronic disease management can be combined into a clinic consultation and impact upon quality of life (QOL) in PBC. AIMS: To develop and implement the first Integrated Care Pathway (ICP) for the management of liver disease progression and symptom management in PBC. METHODS: Process mapping of current practice by a multidisciplinary group developed a flowchart of care from which the clinical record evolved. Symptom assessment is incorporated into the PBC ICP (QOL; PBC-40, autonomic symptoms; Orthostatic Grading Scale, daytime sleepiness; Epworth Sleepiness Scale). All patients were considered who attended clinic between July 2005 and June 2006. Symptom assessment was repeated after 1 year in those participating in the initial clinic cohort. RESULTS: The PBC ICP was successfully introduced into our clinical environment with high levels of patient satisfaction. A total of 225 PBC patients attended over 12 months. Initial QOL assessments were in 195 (87%). Five patients died (3%). Repeat assessment 1 year later occurred in 149 subjects (149/190; 78%). All symptom domains improved after ICP implementation with significant improvements in those with moderate and severe symptoms in all PBC-40 symptom domains (P < 0.02). In those with severe fatigue (n = 38) symptom improvement was even more dramatic (P = 0.002). CONCLUSION: ICP implementation delivers evidence-based care, leads to improvements in QOL coupled with high levels of patient satisfaction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/qjmed/hcn043

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A structured approach to fatigue management, including quantifying fatigue and its impacts, addressing contributing factors, and helping patients cope, has been shown effective.

    “A structured approach to management, quantifying fatigue and its impacts (through the use of tools such as the PBC-40 QoL measure), addressing contributing factors and helping patients to cope with its impact have been shown to be effective [222].”

    From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [222]

    The PBC-40 section describes measuring fatigue and its effects on quality of life. The Discussion describes a care pathway addressing daytime sleepiness, and the outcomes section reports improved fatigue scores among patients with severe fatigue. However, the copy does not establish that helping patients cope was a component of the pathway or an effective component in its own right; the reported fatigue improvement is specific to a subgroup. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • A structured approach to management, quantifying fatigue and its impacts, addressing contributing and exacerbating factors and supporting patients to cope with its impact has been shown to be effective.

    “A structured approach to management, quantifying fatigue and its impacts (through the use of tools such as the PBC-40 QoL measure), addressing contributing and exacerbating factors and supporting patients to cope with its impact has been shown to be effective.212”

    From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [212]

    The PBC-40 section describes measuring fatigue and quality of life, and the Results and Discussion report improved scores after a structured care pathway was introduced for patients with PBC. The Discussion describes addressing daytime sleepiness through sleep hygiene, referral and, where appropriate, modafinil. Our copy does not establish that support to help patients cope with fatigue was a component of the pathway or that this component was effective. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [9]9. Newton JL, Francis RM, Rawlings D, Prince M, Bassendine MF, James OF, et al. Osteoporosis and PBC revisited. Gut 2001; 49:282-7.
  2. [10]10. Jones DEJ, Newton JL. Primary biliary cirrhosis. In: Horizons in Medicine, vol. 17. London, Royal College of Physicians, 2005.
  3. [16]16. Newton JL, Jones DEJ. The population prevalence of autonomic dysfunction and daytime somnolence in Primary biliary cirrhosis. Hepatology 2007; 47:1496-505.

Cited by

Sorted by citations

Authors
Jones, D. E. J., Sutcliffe, K., Pairman, J., Wilton, K., & Newton, J. L.
Affiliations
Newcastle University (GB)
Venue
QJM
Published
2008-03-04
Volume
101
Issue
7
Pages
535-543
ISSN
  • 0033-5622 (ISSN-L)
  • 1460-2725
  • 1460-2393
OpenAlex
W2141276184
Cited by
58
References
22
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2022: 3 · 2021: 7 · 2019: 1 · 2018: 7 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 2
FWCI
5.13
Type
journal article
Language
en
Open access
Locations
  • QJM (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Medical Research Council
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary biliary cirrhosis, integrated care pathways, quality of life, symptom management, fatigue, autonomic symptoms, daytime sleepiness, patient satisfaction, multidisciplinary care
MeSH terms
Algorithms, Continuity of Patient Care, England, Fatigue, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Quality of Life, Sickness Impact Profile, Disease Progression, Critical Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review